Oral presentation describes distinct preclinical profile for potent, selective MALT1 scaffolding inhibitor that is highly differentiated from MALT1 protease inhibitors BOSTON, Dec. 11, 2023 /PRNewswire/ — HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as “natural hotspots,” today announced the… Continue reading HotSpot Therapeutics Presents Preclinical Data for Potential First-in-Class MALT1 Scaffolding Inhibitor at 65th ASH Annual Meeting
Category: Newswire
Hamilton Lane Named a Best Place to Work in Money Management for 12th Consecutive Year
Leading private markets firm is one of only five organizations selected every year since the award was created Recognition comes as the firm expanded its employee base nearly 20% over the last year to meet firm growth across products, channels and geographies CONSHOHOCKEN, Pa., Dec. 11, 2023 /PRNewswire/ — Today, leading private markets investment management… Continue reading Hamilton Lane Named a Best Place to Work in Money Management for 12th Consecutive Year
Remix Therapeutics to Present at 6th Annual RNA-Targeted Drug Discovery & Development Summit
WATERTOWN, Mass., Dec. 11, 2023 /PRNewswire/ — Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that the Company will be participating in the 6th Annual RNA-Targeted Drug Discovery & Development Summit taking place December 12-14, 2023 in Boston, MA. “These… Continue reading Remix Therapeutics to Present at 6th Annual RNA-Targeted Drug Discovery & Development Summit
Poets&Quants™ Names the Top 100 U.S. MBA Programs of 2023-2024
Business school news hub ranks the top 100 MBA programs in the annual composite ranking. SAN FRANCISCO, Dec. 11, 2023 /PRNewswire/ — Poets&Quants, the definitive online publication for business education news, has revealed its annual Top 100 MBA Programs for 2023-2024. Stanford Graduate School of Business returns to the top of the Poets&Quants MBA ranking… Continue reading Poets&Quants™ Names the Top 100 U.S. MBA Programs of 2023-2024
United States Generic Drugs Market Analysis Report 2023-2028: Generic Drugs Fill the Gap During Brand-Name Drug Shortages in Healthcare
DUBLIN, Dec. 11, 2023 /PRNewswire/ — The “United States Generic Drugs Market, Competition, Forecast and Opportunities, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. United States Generic Drugs Market has valued at USD 104.23 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 7.46% through 2028. … Continue reading United States Generic Drugs Market Analysis Report 2023-2028: Generic Drugs Fill the Gap During Brand-Name Drug Shortages in Healthcare
cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance
GRAND RAPIDS, Mich., Dec. 11, 2023 /PRNewswire/ — cultivate(MD), a leader in medical device venture capital, is thrilled to announce that one of its portfolio companies, NSite Medical, has received FDA clearance for its groundbreaking AI-based scoliosis scanning application. This marks a significant milestone in advancing medical technology and offering new, innovative solutions for scoliosis management.… Continue reading cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance
Highlander Partners Announces Palmex and Benestar Brands Merger And Pretzilla Spin-off
DALLAS, Dec. 11, 2023 /PRNewswire/ — Highlander Partners, L.P. (“Highlander”), a Dallas-based private investment firm, today announced the merger of its portfolio company, Benestar Brands (“Benestar”), with Palmex S. de R.L. de C.V. (“Palmex” or the “Company”), a portfolio company of Wind Point Partners (“Wind Point”). In this strategic move, Wind Point will become the majority… Continue reading Highlander Partners Announces Palmex and Benestar Brands Merger And Pretzilla Spin-off
Cancer Biopsy Market Surpass $67.11 billion by 2030 – Exclusive Report by Coherent Market Insights
BURLINGAME, Calif., Dec. 11, 2023 /PRNewswire/ — According to Coherent Market Insights, The global cancer biopsy market was valued at US$ 25.61Billion in 2023 and is forecast to reach a value of US$ 67.11 Billion by 2030 at a CAGR of 14.7% between 2023 and 2030. The Cancer Biopsy Market is expected to witness high growth due… Continue reading Cancer Biopsy Market Surpass $67.11 billion by 2030 – Exclusive Report by Coherent Market Insights
Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Keppel Corporation Limited (Keppel), through its Infrastructure Division, and AM Green, which is wholly owned and controlled by the founders of Hyderabad-based Greenko Group, have signed a Memorandum of Understanding (MOU) to jointly explore opportunities to produce biogenic carbon-based sustainable fuels, such as bio and green… Continue reading Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
Taylor Morrison ‘Builds Joy’ Across the Country this Holiday Season
For the seventh year, national homebuilder funds team members’ philanthropic ideas SCOTTSDALE, Ariz., Dec. 11, 2023 /PRNewswire/ — For the seventh consecutive year, America’s Most Trusted® Home Builder Taylor Morrison (NYSE: TMHC) is putting the power of giving in the hands of its team members with its annual philanthropic program, Build Joy. This year, 10… Continue reading Taylor Morrison ‘Builds Joy’ Across the Country this Holiday Season